Return to search

CureVac files for U.S. IPO: Reuters

German biotech CureVac, which is developing a coronavirus vaccine, has filed for a U.S. IPO, reported Reuters.

German biotech CureVac, which is developing a coronavirus vaccine, has filed for a U.S. IPO, reported Reuters. CureVac’s backers include Qatar Investment Authority and GlaxoSmithKline Plc.

Source: Reuters